RT Journal Article
SR Electronic
T1 In-hospital Death Following Successful OHCA Resuscitation: Causes of early and late mortality and the impact of withdrawal of care
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.15.20029207
DO 10.1101/2020.03.15.20029207
A1 Li, Shu
A1 Lazaridis, Christos
A1 Goldenberg, Fernando D.
A1 Shah, Atman P.
A1 Tataris, Katie
A1 Beiser, David G.
A1 Sharp, Willard W.
YR 2020
UL http://medrxiv.org/content/early/2020/04/23/2020.03.15.20029207.abstract
AB Objective In-hospital mortality in patients successfully resuscitated following out-of-hospital cardiac arrest (OHCA) is high. The factors and timings of these deaths is not well known. To better understand in hospital post-OHCA mortality we developed a novel categorization system of in hospital death and studied the factors and timings associated with these deaths.Methods This was a single-centered retrospective observational human study in adult non-traumatic OHCA patients in a university affiliated hospital. Through an expert consensus process, a novel classification system of hospital death was developed.Results Two hundred and forty-one patients were enrolled in the study. Death was categorized as due to withdrawal of life sustaining treatment (WOLST) 159 (66.0%), recurrent in-hospital cardiac arrest 51 (21.1%), or due to neurological criteria 31 (12.9%). Subcategorization of factors associated with WOLST into 7 categories was done by defined criteria. Inter-reliability of this system was 0.858. 50% of WOLST decisions were due to neurological injury. Early death (≤ 3 days) was associated with recurrent in-hospital cardiac arrest and WOLST in the setting of refractory shock or multi-organ injury. Late in-hospital death (> 3 days) was primarily due to WOLST decisions in the setting of isolated neurological injury.Conclusions OHCA in hospital mortality occurred in a bimodal pattern with early deaths due to recurrent arrest and multiorgan injury while late deaths were due to isolated neurological injury. The majority of deaths occurred in the setting of WOLST decisions. Further study of the influence of these factors on post OHCA survival are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for Dr. Shu Li MD was provided by Clinical Leadership Development Fellowship of Peking University Third Hospital (2018, China). Funding for Dr. Willard W. Sharp was provided by NIH R01HL133675-03. The remaining authors have disclosed that there is no financial, consultant, institutional, and other relationships that might lead to bias or a conflict of interest.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTo facilitate this study and to monitor quality of care, a REDCAP HIPPA secure registry was maintained with EMR as source data.